62
Participants
Start Date
June 1, 2024
Primary Completion Date
March 5, 2025
Study Completion Date
March 5, 2025
Sugammadex
"After the last dose of rocuronium, at reappearance of T2, a dose of 2.0 mg/kg sugammadex was administered.~Dose will be according to participant actual body weight."
Neostigmine
"After the last dose of rocuronium, at reappearance of T2, a dose of 50 ug/kg neostigmine (up to 5 mg maximum dose) plus atropine 0.02 mg/kg (up to 2 mg maximum dose) was administered.~Dose will be according to participant actual body weight."
Beijing tongren Hospital, Capital Medical University, Beijing
The First Affiliated Hospital with Nanjing Medical University, Nanjing
The First Affiliated Hospital with Nanjing Medical University
OTHER
Beijing Tongren Hospital
OTHER